Skip to content

Commit

Permalink
regular backup
Browse files Browse the repository at this point in the history
  • Loading branch information
kamranmuazzam committed Dec 9, 2024
1 parent 36baf34 commit f63de5e
Show file tree
Hide file tree
Showing 187 changed files with 6,145 additions and 392 deletions.
Original file line number Diff line number Diff line change
@@ -0,0 +1,74 @@
- alias::
ICD-11_Code::
- ## Etiology #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 36de9f45-68c5-4331-8e37-c3daf391bb23
- ### Causative Agents
- ### Risk Factors
- ## Epidemiology
background-color:: blue
- ### Incidence
- ### Prevalence
- ### Demographics
- ### Geographic Distribution
- ## Pathophysiology
background-color:: blue
- ### Mechanism of Disease
- ### Affected Systems/Organs
- ## Clinical Features #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 52c64503-bf27-4d6a-8474-e752eb17a295
- ### Signs and Symptoms
- #### Symptoms
- #### Signs
- ### Stages or Classification
- ### Diagnostic Criteria
- ## Diagnosis
background-color:: blue
- ### Clinical Diagnosis
- #### Classical Presentation
- #### Probable Diagnosis
- ### Laboratory Tests
- ### Imaging Studies
- ### Differential Diagnosis
- ### Confirmation of Diagnosis
- ## Management and Treatment #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 2d2ff087-298c-43ec-a324-fce7ddfa9dfa
- ### Medical Treatment
- ### Surgical Options
- ### Lifestyle and Dietary Recommendations
- ### Follow-up
- ## Prognosis
background-color:: blue
- ### Expected Course
- #### With Treatment
- #### Without Treatment
- ##### Possible Complications
- ##### Long-Term Effects
- ### Survival Rates
- #### With Treatment
- #### Without Treatment
- ### Quality of Life Considerations
- ## Prevention
background-color:: blue
- ### Health Education
- ### Community Approach
- ### Screening Programs
- ### Lifestyle Modifications
- ## Patient Education and Support
background-color:: blue
- ### Educational Resources
- ### Support Groups
- ### Counseling Options
- ## Recent Research and Developments
background-color:: blue
- ### Ongoing Clinical Trials
- ### Recent Advances
- ## Key Literature
background-color:: blue
- ## Guidelines and Protocols
background-color:: blue
Original file line number Diff line number Diff line change
@@ -0,0 +1,75 @@
- alias::
ICD-11_Code::
- #definition {{c1 }} #ent-prof-card #card
deck:: #ENT
id:: 6756c304-3499-4275-8d91-49419983f0cc
- ## Etiology
background-color:: blue
- ### Causative Agents
- ### Risk Factors
- ## Epidemiology
background-color:: blue
- ### Incidence
- ### Prevalence
- ### Demographics
- ### Geographic Distribution
- ## Pathophysiology
background-color:: blue
- ### Mechanism of Disease
- ### Affected Systems/Organs
- ## Clinical Features
background-color:: blue
- ### Signs and Symptoms
- #### Symptoms
- #### Signs
- ### Stages or Classification
- ### Diagnostic Criteria
- ## Diagnosis #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 55f72805-d6eb-4212-990f-cc2cd81152c3
- ### Clinical Diagnosis
- #### Classical Presentation
- #### Probable Diagnosis
- ### Laboratory Tests
- ### Imaging Studies
- ### Differential Diagnosis
- ### Confirmation of Diagnosis
- ## Management and Treatment #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: f9d9dedb-3efc-4deb-bde8-e714cd3afa45
- ### Medical Treatment
- ### Surgical Options
- ### Lifestyle and Dietary Recommendations
- ### Follow-up
- ## Prognosis
background-color:: blue
- ### Expected Course
- #### With Treatment
- #### Without Treatment
- ##### Possible Complications
- ##### Long-Term Effects
- ### Survival Rates
- #### With Treatment
- #### Without Treatment
- ### Quality of Life Considerations
- ## Prevention
background-color:: blue
- ### Health Education
- ### Community Approach
- ### Screening Programs
- ### Lifestyle Modifications
- ## Patient Education and Support
background-color:: blue
- ### Educational Resources
- ### Support Groups
- ### Counseling Options
- ## Recent Research and Developments
background-color:: blue
- ### Ongoing Clinical Trials
- ### Recent Advances
- ## Key Literature
background-color:: blue
- ## Guidelines and Protocols
background-color:: blue
Original file line number Diff line number Diff line change
@@ -0,0 +1,78 @@
- alias::
ICD-11_Code::
- ## Etiology #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 679efe77-ff1d-4c8d-888c-abb551b9ada2
- ### Causative Agents
- ### Risk Factors
- ## Epidemiology
background-color:: blue
- ### Incidence
- ### Prevalence
- ### Demographics
- ### Geographic Distribution
- ## Pathophysiology
background-color:: blue
- ### Mechanism of Disease
- ### Affected Systems/Organs
- ## Clinical Features #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 594754be-5664-46ab-8213-ccbed28261b5
- ### Signs and Symptoms
- #### Symptoms
- #### Signs
- ### Stages or Classification
- ### Diagnostic Criteria
- ## Diagnosis
background-color:: blue
- ### Clinical Diagnosis
- #### Classical Presentation
- #### Probable Diagnosis
- ### Laboratory Tests
- ### Imaging Studies
- ### Differential Diagnosis
- [[Acute Laryngotracheobronchitis]]
- Differences #ent-prof-card #card
deck:: #ENT
id:: 6756b395-74e9-4b44-83bd-651dc5aeded1
- ### Confirmation of Diagnosis
- ## Management and Treatment #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 4ef3c41d-da98-42b2-ae51-71ddb4f116d4
- ### Medical Treatment
- ### Surgical Options
- ### Lifestyle and Dietary Recommendations
- ### Follow-up
- ## Prognosis
background-color:: blue
- ### Expected Course
- #### With Treatment
- #### Without Treatment
- ##### Possible Complications
- ##### Long-Term Effects
- ### Survival Rates
- #### With Treatment
- #### Without Treatment
- ### Quality of Life Considerations
- ## Prevention
background-color:: blue
- ### Health Education
- ### Community Approach
- ### Screening Programs
- ### Lifestyle Modifications
- ## Patient Education and Support
background-color:: blue
- ### Educational Resources
- ### Support Groups
- ### Counseling Options
- ## Recent Research and Developments
background-color:: blue
- ### Ongoing Clinical Trials
- ### Recent Advances
- ## Key Literature
background-color:: blue
- ## Guidelines and Protocols
background-color:: blue
Original file line number Diff line number Diff line change
@@ -0,0 +1,72 @@
- alias::
ICD-11_Code::
- ## Etiology
background-color:: blue
- ### Causative Agents
- ### Risk Factors
- ## Epidemiology
background-color:: blue
- ### Incidence
- ### Prevalence
- ### Demographics
- ### Geographic Distribution
- ## Pathophysiology
background-color:: blue
- ### Mechanism of Disease
- ### Affected Systems/Organs
- ## Clinical Features
background-color:: blue
- ### Signs and Symptoms
- #### Symptoms
- #### Signs
- ### Stages or Classification
- ### Diagnostic Criteria
- ## Diagnosis
background-color:: blue
- ### Clinical Diagnosis
- #### Classical Presentation
- #### Probable Diagnosis
- ### Laboratory Tests
- ### Imaging Studies
- ### Differential Diagnosis
- [[Furunculosis]]
- Differences #ent-prof-card #card
deck:: #ENT
id:: 6756bf74-1837-4386-b65d-01fd1761851d
- ### Confirmation of Diagnosis
- ## Management and Treatment
background-color:: blue
- ### Medical Treatment
- ### Surgical Options
- ### Lifestyle and Dietary Recommendations
- ### Follow-up
- ## Prognosis
background-color:: blue
- ### Expected Course
- #### With Treatment
- #### Without Treatment
- ##### Possible Complications
- ##### Long-Term Effects
- ### Survival Rates
- #### With Treatment
- #### Without Treatment
- ### Quality of Life Considerations
- ## Prevention
background-color:: blue
- ### Health Education
- ### Community Approach
- ### Screening Programs
- ### Lifestyle Modifications
- ## Patient Education and Support
background-color:: blue
- ### Educational Resources
- ### Support Groups
- ### Counseling Options
- ## Recent Research and Developments
background-color:: blue
- ### Ongoing Clinical Trials
- ### Recent Advances
- ## Key Literature
background-color:: blue
- ## Guidelines and Protocols
background-color:: blue
Original file line number Diff line number Diff line change
@@ -0,0 +1,76 @@
- alias::
ICD-11_Code::
- ## Etiology #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 3fae41d5-d42b-4c21-9e86-58cedddcc339
- ### Causative Agents
- ### Risk Factors
- ## Epidemiology
background-color:: blue
- ### Incidence
- ### Prevalence
- ### Demographics
- ### Geographic Distribution
- ## Pathophysiology
background-color:: blue
- ### Mechanism of Disease
- ### Affected Systems/Organs
- ## Clinical Features #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: 00ed145a-4123-46b2-8747-008133352fc0
- ### Signs and Symptoms
- #### Symptoms
- #### Signs
- ### Stages or Classification
- ### Diagnostic Criteria
- ## Diagnosis
background-color:: blue
- ### Clinical Diagnosis
- #### Classical Presentation
- #### Probable Diagnosis
- ### Laboratory Tests
- ### Imaging Studies
- ### Differential Diagnosis
- ### Confirmation of Diagnosis
- ## Management and Treatment #ent-prof-card #card
background-color:: blue
deck:: #ENT
id:: e0e6c817-331f-4915-8c21-e69e459165b0
- ### Medical Treatment
- ### Surgical Options
- ### Lifestyle and Dietary Recommendations
- ### Follow-up
- ## Prognosis
background-color:: blue
- ### Expected Course
- #### With Treatment
- #### Without Treatment
- ##### Complications #ent-prof-card #card
deck:: #ENT
id:: 481a1175-c18c-4f1f-9336-7f2707e71ffd
- ##### Long-Term Effects
- ### Survival Rates
- #### With Treatment
- #### Without Treatment
- ### Quality of Life Considerations
- ## Prevention
background-color:: blue
- ### Health Education
- ### Community Approach
- ### Screening Programs
- ### Lifestyle Modifications
- ## Patient Education and Support
background-color:: blue
- ### Educational Resources
- ### Support Groups
- ### Counseling Options
- ## Recent Research and Developments
background-color:: blue
- ### Ongoing Clinical Trials
- ### Recent Advances
- ## Key Literature
background-color:: blue
- ## Guidelines and Protocols
background-color:: blue
Loading

0 comments on commit f63de5e

Please sign in to comment.